AKT1 and chronic obstructive pulmonary disease: It has been revealed that glycyrrhizic acid could alleviate inflammatory lung disease, including chronic obstructive pulmonary disease by promoting the downstream PI3K/Akt/GSK3β signaling pathway [66].